Inguinal endometriosis: pathogenetic and clinical implications

…, N VENDOLA, S CARINELL, V SCAGLIONE - Obstetrics & …, 1991 - journals.lww.com
Clinical Implications Page 1 Inguinal Endometriosis: Pathogenetic and Clinical Implications
GIOVANNI BATTISTA CANDIANI, MD, PAOLO VERCELLINI, MD, LUIGI PEDELE, MD …

[HTML][HTML] Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility

…, B Tassone, E Arrighi, G Perri, P Fusco, V Scaglione… - Scientific reports, 2020 - nature.com
Since December 2019, coronavirus disease 2019 (COVID-19) pandemic has spread from
China all over the world and many COVID-19 outbreaks have been reported in long-term care …

Successful treatment with cefiderocol for compassionate use in a critically ill patient with XDR Acinetobacter baumannii and KPC-producing Klebsiella pneumoniae …

EM Trecarichi, A Quirino, V Scaglione… - Journal of …, 2019 - academic.oup.com
Sir, Cefiderocol is a new siderophore cephalosporin, with potent activity against MDR Gram-negative
bacilli. It is particularly active against XDR Acinetobacter baumannii (Ab) infections, …

[HTML][HTML] Cefiderocol-Based versus Colistin-Based Regimens for Severe Carbapenem-Resistant Acinetobacter baumannii Infections: A Propensity Score-Weighted …

…, D Gregori, L Sasset, M Trevenzoli, V Scaglione… - Microorganisms, 2023 - mdpi.com
Background. A large increase in multi-drug-resistant Acinetobacter baumannii, especially
carbapenem-resistant strains, occurred during the first two years of the COVID-19 pandemic, …

Risk of hospitalization and sequelae in patients with COVID‐19 treated with 3‐day early remdesivir vs. controls in the vaccine and Omicron era: A real‐life cohort study

…, M Trunfio, L Sasset, V Scaglione… - Journal of Medical …, 2023 - Wiley Online Library
Recently, a benefit from administration of a 3‐day course of early remdesivir (ER) in the
outpatients' setting was reported. However, real‐life data on its use is scarce. Therefore, we …

[HTML][HTML] Molnupiravir and nirmatrelvir/ritonavir: tolerability, safety, and adherence in a retrospective cohort study

…, D Mengato, L Sasset, A Ferrari, S Gardin, V Scaglione… - Viruses, 2023 - mdpi.com
Background. Molnupiravir (MOL) and nirmatrelvir/ritonavir (NIR) were recently approved for
the early treatment of COVID-19, but real-life data on tolerability, safety, and adverse events (…

Oxygen therapy via high flow nasal cannula in severe respiratory failure caused by Sars-Cov-2 infection: a real-life observational study

…, MC Pelle, M Ricchio, V Scaglione… - Therapeutic …, 2020 - journals.sagepub.com
The worldwide spread of coronavirus disease 2019 (COVID-19), caused by the new severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was declared a pandemic by the …

[HTML][HTML] Is the pendulum of antimicrobial drug resistance swinging back after COVID-19?

F Serapide, A Quirino, V Scaglione, HL Morrone… - Microorganisms, 2022 - mdpi.com
The COVID-19 pandemic may have had an effect on antimicrobial resistance. We compared
the prevalence of ESKAPE multidrug-resistant (MDR) bacterial infections in COVID-19 …

The first case of monkeypox virus and acute HIV infection: Should we consider monkeypox a new possible sexually transmitted infection?

M Brundu, S Marinello, V Scaglione… - The Journal of …, 2023 - Wiley Online Library
Since May 2022, a Monkeypox virus (MPXV) outbreak has been ongoing in several non‐endemic
countries. MPXV is usually transmitted after intimate contact, through body fluids, close …

Sleep disturbances and their correlation with cardiovascular risk, obesity, and mood disorders in people with HIV

…, P Balducci, GCQ Ribeiro, G Filagrana, V Scaglione… - Aids, 2023 - journals.lww.com
Background: The relationship between sleep disorders (SDs), cardiovascular risk (CVR), and
mood disorders (MDs) has been studied in detail in the general population, but far less in …